Xico Gracida, PhD
Xico joined Royalty Pharma in 2021. He is a molecular biologist with a background in RNA and neuroscience. Until the fall of 2020, he was a postdoctoral research fellow at Harvard University working on alternative mRNA splicing in neurons. There, he also completed a program for scientists called the “mini-MBA” at the Harvard Business School. Prior joining RP, he did an internship at RTW Investments, a biotech investment fund in NYC.
Xico has a BA in Biology from the Universidad Nacional Autónoma de México (UNAM) and a PhD in Developmental and Germ Cell Biology from Max Planck Institute for Cell Biology and Genetics.